Today: 10 June 2026
Browse Category

NYSE:DDS 13 November 2025 - 22 December 2025

Dillard’s Stock (DDS) Drops on Dec. 22, 2025: Today’s News, Special Dividend Details, and Wall Street Forecasts

Dillard’s Stock (DDS) Drops on Dec. 22, 2025: Today’s News, Special Dividend Details, and Wall Street Forecasts

Dillard’s shares fell about 8% Monday, trading near $610 after hitting highs above $660 earlier in the day. The drop followed a year of strong gains, with the stock still up roughly 47% year-to-date. Analysts cited valuation concerns and mixed Wall Street signals as drivers of volatility. Q3 results showed net sales of $1.469 billion and net income of $129.8 million.
22 December 2025
··
Dillard’s (DDS) Stock Today: Special Dividend Fallout, Q3 Results, and the Latest Analyst Forecasts (Dec. 16, 2025)

Dillard’s (DDS) Stock Today: Special Dividend Fallout, Q3 Results, and the Latest Analyst Forecasts (Dec. 16, 2025)

Dillard’s stock fell 4.9% Tuesday to $645.61 after hitting an all-time high near $742 on Dec. 11, 2025. The drop follows a surge driven by a $30 special dividend, payable Jan. 5 to holders as of Dec. 12. In Q3, Dillard’s reported net sales of $1.469 billion and net income of $129.8 million, both up from a year earlier.
16 December 2025
···
Dillard’s (DDS) Surges After Q3 Beat: EPS $8.31 on $1.47B Sales, Comps +3%; Plano Willow Bend Exit Confirmed — November 13, 2025

Dillard’s (DDS) Surges After Q3 Beat: EPS $8.31 on $1.47B Sales, Comps +3%; Plano Willow Bend Exit Confirmed — November 13, 2025

Dillard’s shares surged over 16% intraday after reporting fiscal Q3 earnings of $8.31 per share on $1.47 billion revenue, both topping analyst estimates. Comparable store sales rose 3%, and gross margin improved to 45.3%. The company repurchased 300,000 shares year-to-date and will close its Plano, Texas store in January, affecting 93 jobs.
13 November 2025
··

Stock Market Today

  • Insider Buying Highlights: BORR Director Buys $5M Shares, GBFH Insider Purchases 28,000 Shares
    June 10, 2026, 12:25 PM EDT. Insider buying signals confidence in stock prospects. Borr Drilling director Tor Olav Troim bought 1.06 million shares worth $5 million at $4.70 each, just above Wednesday's low of $4.60. This marks Troim's third purchase in a year, averaging $5.39 per share. Borr shares rose 2.2% Wednesday. At Gbank Financial Holdings, insider Charles William Griege Jr. acquired 28,000 shares for $812,000 at $29 apiece on Friday, following a previous purchase at $33.30. GBFH shares climbed 2.3%, putting Griege Jr. roughly 8.4% ahead based on the current $31.45 trading price. Insider buying often implies expectations of future gains, benefitting savvy investors.

Latest articles

Ford Shares Slide as F-150 Aluminum Constraint Eases

Ford Shares Slide as F-150 Aluminum Constraint Eases

10 June 2026
Ford shares slid 3.2% to $14.47 despite Novelis restarting its Oswego aluminum plant, a key F-Series supplier, as investors now focus on how quickly supply ramps up to cut costs and boost production after months of disruption that forced Ford to cut its 2025 profit forecast and warn of up to $2 billion in charges.
Broadcom Shares Slip After $35 Billion AI Transaction, Guidance Jitters Linger

Broadcom Shares Slip After $35 Billion AI Transaction, Guidance Jitters Linger

10 June 2026
Broadcom shares plunged 4% to $376.42 despite unveiling a $35 billion AI infrastructure deal with Apollo and Blackstone, as investors fixated on last week’s softer-than-expected AI chip revenue guidance and ongoing concerns over high valuation, customer concentration, and margin risks tied to new AI financing models.
Palantir CEO Karp takes aim at AI spend by Anthropic, OpenAI

Palantir CEO Karp takes aim at AI spend by Anthropic, OpenAI

10 June 2026
Palantir shares edged up less than 1% to $132.66 after CEO Alex Karp told CNBC that enterprise customers are privately “unhappy” with frontier AI labs’ billing practices, as AI buyers face “sticker shock” and cost savings lag, while Palantir pitches its software and embedded engineers as a solution amid ongoing scrutiny of its NHS contract in Britain.
Go toTop